Viewing Study NCT04729959


Ignite Creation Date: 2025-12-24 @ 2:41 PM
Ignite Modification Date: 2025-12-26 @ 2:45 PM
Study NCT ID: NCT04729959
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-20
First Post: 2021-01-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module